SF188 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SF188 cell line is a human glioblastoma multiforme (GBM) model established from a pediatric patient. It is used extensively to study the mechanisms of chemotherapeutic resistance, particularly to alkylating agents such as 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Compared to other glioma-derived cell lines such as SF126, SF188 exhibits significantly higher resistance to BCNU-induced cytotoxicity and genotoxicity. Specifically, SF188 shows approximately threefold greater resistance in survival assays and 14-fold lower susceptibility to BCNU-induced sister chromatid exchange (SCE), indicating a robust DNA damage tolerance phenotype. The resistance in SF188 is attributed to enhanced DNA repair capacity, especially the rapid and efficient removal of O6-alkylguanine adducts. Upon exposure to methylating agents like N-methyl-N-nitrosourea, SF188 cells demonstrate marked removal of O6-methylguanine lesions, whereas more sensitive cell lines show minimal repair activity. This efficient lesion repair likely prevents the formation of interstrand crosslinks, thereby maintaining genomic integrity and increasing cell survival. Importantly, SF188 also exhibits a high chromosomal count (modal number 91) and lacks expression of glial fibrillary acidic protein (GFAP), confirming its poorly differentiated glioma origin and making it an excellent model for studying the interplay between DNA repair and chemoresistance in high-grade gliomas. |
|---|---|
| Organism | Human |
| Tissue | Brain, right frontal lobe |
| Disease | Glioblastoma |
| Synonyms | SF-188, SF 188 |
Characteristics
| Age | 8 years |
|---|---|
| Gender | Male |
Regulatory Data
| Citation | SF188 (Cytion catalog number 305870) |
|---|---|
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_6948 |
Biomolecular Data
| Mutational profile | Mutation: TP53, Simple, p.Gly266Glu (c.797G>A), Homozygous (PubMed=9614553, PubMed=10416987). |
|---|
Handling
| Doubling time | 26 hours |
|---|---|
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|